Ethical dilemmas: Should antipsychotics ever be prescribed for people with dementia?

British Journal of Psychiatry

Volumn 197, Issue 2, 2010, Pages 88-90

  Treloar, Adrian ^a   Crugel, Monica ^a   Prasanna, Aparna ^b,c   Solomons, Luke ^d   Fox, Chris ^e   Paton, Carol ^a,f   Katona, Cornelius ^g  

^a OXLEAS NHS FOUNDATION TRUST   (United Kingdom)

^b University Hospitals Coventry and Warwickshire NHS Trust   (United Kingdom)

^c North Warwickshire NHS Trust   (United Kingdom)

^d SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^e KENT AND MEDWAY NHS AND SOCIAL CARE PARTNERSHIP TRUST   (United Kingdom)

^f Prescribing Observatory for Mental Health   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE; SULPIRIDE;

DEMENTIA; DISTRESS SYNDROME; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED PRACTICE; HALLUCINATION; HUMAN; LIFE EXPECTANCY; MEDICAL ETHICS; PARANOIA; PSYCHOSIS; REVIEW; RISK BENEFIT ANALYSIS;

ANTIPSYCHOTIC AGENTS; DEMENTIA; FEMALE; HUMANS; MALE; PALLIATIVE CARE;

EID: 77955402712     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.076307     Document Type: Review

References (10)

1. Ropacki S, Jeste D. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005; 162: 2022-30.
2. Lyketsos CG, Lopez O, Jones B, Fitzpatrick A, Breitner J, Dekosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002; 288: 1475-83.
3. Ong C-K, Forbes D. Embracing Cicely Saunders's concept of total pain. BMJ 2005; 331: 576-7.
4. Zwakhalen SM, Hamers JP, Abu-saad HH, Berger MP. Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. BMC Geriatrics 2006; 6: 3.
5. Nuffield Council on Bioethics. Dementia: Ethical Issues. Nuffield Council on Bioethics, 2009.
6. Banerjee S. The Use of Antipsychotic Medication for People with Dementia: Time for Action. Department of Health, 2009.
7. National Institute for Health and Clinical Excellence. Dementia: Supporting People with Dementia and their Carers in Health and Social Care. NICE, 2006 (http://www.nice.org.uk/guidance/cg42).
8. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994; 271: 358-62.
9. All-Party Parliamentary Group on Dementia. Always a Last Resort. Inquiry into the Prescription of Antipsychotic Drugs to People with Dementia living in Care Homes. Alzheimer's Society, 2008.
10. Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009; 8: 151-7.